esophagogastric junction
Showing 1 - 5 of 5
Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,
Recruiting
- Gastric Adenocarcinoma
- +2 more
- Surgery
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Gastric Adenocarcinoma, Gastric Cancer, Esophagogastric Junction Trial run by the NCI (Paclitaxel, Capecitabine, BardPort
Recruiting
- Gastric Adenocarcinoma
- +3 more
- Paclitaxel
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)
Active, not recruiting
- Gastric Cancer
- +2 more
- BMS-986213
- +4 more
-
Clovis, California
- +77 more
Jan 9, 2023
Gastrointestinal Tumors, Esophagogastric Junction Trial in Worldwide (Durvalumab, FLOT chemo)
Active, not recruiting
- Gastrointestinal Neoplasms
- Esophagogastric Junction
- Durvalumab
- FLOT chemotherapy
-
Duarte, California
- +158 more
Oct 3, 2022
Tumors, Lymphoma, Adenocarcinoma Trial in Kashiwa, Matsuyama, Tokyo (Part 1: JNJ-42756493, Part 2: JNJ-42756493)
Completed
- Neoplasms
- +3 more
- Part 1: JNJ-42756493
- Part 2: JNJ-42756493
-
Kashiwa, Japan
- +2 more
May 13, 2019